ZNF687 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.313000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.930800E-01
Normal-vs-Stage2
3.126000E-01
Normal-vs-Stage3
1.131760E-01
Normal-vs-Stage4
8.315200E-01
Stage1-vs-Stage2
6.502800E-01
Stage1-vs-Stage3
5.271800E-02
Stage1-vs-Stage4
3.852400E-01
Stage2-vs-Stage3
1.297040E-01
Stage2-vs-Stage4
1.041350E-01
Stage3-vs-Stage4
1.232640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.764800E-01
Normal-vs-AfricanAmerican
8.882200E-01
Normal-vs-Asian
7.799000E-01
Caucasian-vs-AfricanAmerican
8.400400E-02
Caucasian-vs-Asian
4.519200E-01
AfricanAmerican-vs-Asian
4.974400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.391000E-01
Normal-vs-Female
3.441400E-01
Male-vs-Female
9.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.322600E-01
Normal-vs-Age(41-60Yrs)
4.516400E-01
Normal-vs-Age(61-80Yrs)
3.441400E-01
Normal-vs-Age(81-100Yrs)
6.368400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.604800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.279000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.063400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.841000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.278200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.232430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.855580E-01
Normal-vs-Daily Drinker
1.646810E-01
Normal-vs-Weekly Drinker
4.870200E-01
Normal-vs-Occasional Drinker
9.248400E-01
Normal-vs-Social Drinker
4.876600E-01
Non Drinker-vs-Daily Drinker
6.489800E-01
Non Drinker-vs-Weekly Drinker
5.792600E-01
Non Drinker-vs-Occasional Drinker
5.839400E-03
Non Drinker-vs-Social Drinker
1.733200E-01
Daily Drinker-vs-Weekly Drinker
4.165000E-01
Daily Drinker-vs-Occasional Drinker
4.882600E-03
Daily Drinker-vs-Social Drinker
1.069820E-01
Weekly Drinker-vs-Occasional Drinker
1.274650E-01
Weekly Drinker-vs-Social Drinker
6.231200E-01
Occasional Drinker-vs-Social Drinker
1.808020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.722100E-02
Normal-vs-Grade 2
6.341200E-03
Normal-vs-Grade 3
3.997400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.791400E-01
Grade 1-vs-Grade 3
2.340400E-01
Grade 1-vs-Grade 4
2.722100E-02
Grade 2-vs-Grade 3
2.562800E-01
Grade 2-vs-Grade 4
6.341200E-03
Grade 3-vs-Grade 4
3.997400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.330400E-01
Normal-vs-NonDiabetic
4.159000E-01
Diabetic-vs-NonDiabetic
1.930170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.177200E-01
Normal-vs-NoPancreatitis
3.463600E-01
Pancreatitis-vs-NoPancreatitis
9.069600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.025800E-01
Normal-vs-N1
2.276400E-01
N0-vs-N1
4.094400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.101400E-01
Normal-vs-TP53-NonMutant
8.254000E-01
TP53-Mutant-vs-TP53-NonMutant
6.546200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
